DigestRedComo funciona
Red
/
Empresas
En
No verificado

Encoded Therapeutics Inc.

Sobre qué escribimos

BiotecnologíaFarmacéuticaIndustriaMedicina - VariosSalud

8 Comunicados de prensa

Ver todos los comunicados de prensa
05/12/2025
Ciencia
Farmacéutica
Ir de compras
Biotecnología
Infancia
Medicina - Varios
Asistencia a la infancia
Higiene alimentaria
Salud
Eventos
Industria
Encoded Therapeutics Presents Positive Interim Efficacy Data from Initial Dose Levels of Phase 1/2 Trials Evaluating ETX101 Gene Therapy in Dravet Syndrome
Fuente
Encoded Therapeutics Inc.
Editor
Business Wire
1.00
0
01/12/2025
Ciencia
Higiene alimentaria
Biotecnología
Medicina - Varios
Salud
Farmacéutica
Sanidad
Eventos
Industria
Encoded Therapeutics to Present Interim Phase 1/2 Clinical Data on ETX101, the First One-time Gene Therapy in Development for Dravet Syndrome, at the 2025 American Epilepsy Society Annual Meeting
Fuente
Encoded Therapeutics Inc.
Editor
Business Wire
1.00
0
09/10/2025
Ciencia
Biotecnología
Medicina - Varios
Sanidad
Farmacéutica
Salud
Industria
New Preclinical Data from Encoded Therapeutics Demonstrate Therapeutic Potential of its One-time, Non-opioid Gene Therapy Candidate for Chronic Pain
Fuente
Encoded Therapeutics Inc.
Editor
Business Wire
1.00
0
02/09/2025
Salud
Higiene alimentaria
Biotecnología
Medicina - Varios
Farmacéutica
Industria
Encoded Therapeutics Announces Regenerative Medicine Advanced Therapy (RMAT) Designation Granted by U.S. FDA for ETX101 in SCN1A+ Dravet Syndrome
Fuente
Encoded Therapeutics Inc.
Editor
Business Wire
1.00
0
13/05/2025
Eventos
Industria
Psiquiatría
Ciencia
Biotecnología
Medicina - Varios
Salud
Farmacéutica
Encoded Therapeutics Presents Promising New Data for CNS Gene Therapy Programs at the ASGCT 28th Annual Meeting
Fuente
Encoded Therapeutics Inc.
Editor
Business Wire
1.00
0
28/04/2025
Eventos
Ferias y Congresos
Biotecnología
Farmacéutica
Salud
Encoded Therapeutics to Present New Data for CNS Gene Therapy Programs at the ASGCT 28th Annual Meeting
Fuente
Encoded Therapeutics Inc.
Editor
Business Wire
1.00
0
13/02/2025
Biotecnología
Salud
Farmacéutica
Medicina - Varios
Industria
Encoded Therapeutics Reports Clinical Progress of ETX101 Gene Therapy for Dravet Syndrome, Recaps 2024 Corporate Achievements and Provides 2025 Outlook
Fuente
Encoded Therapeutics Inc.
Editor
Business Wire
1.00
0
07/11/2024
Eventos
Industria
Ciencia
Biotecnología
Medicina - Varios
Sanidad
Salud
Farmacéutica
Encoded Demonstrates Therapeutic Potential of a Vectorized miRNA-based Approach for Angelman Syndrome at the FAST Annual Global Science Summit
Fuente
Encoded Therapeutics Inc.
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0